Fulgent Genetics to buy Bako Diagnostics assets and StrataDx
Fulgent Genetics has signed a definitive agreement to buy specific assets of Bako Diagnostics and to acquire StrataDx, two US-based laboratories,…
News
FDA approves Abbott’s Volt PFA system for atrial fibrillation
Neurable secures $35m to expedite BCI technology commercialisation
ZOLL introduces next-gen wearable cardioverter defibrillator in US
CellBxHealth’s new CEO pivots strategy amid financial turnaround efforts
Curasight doses first patient in Phase I brain cancer trial of uTREAT
Abbott secures FDA and CE Mark approvals for Amplatzer delivery system
EDX Medical plans UK bowel cancer testing service launch
